You are here: Industry Insights > Covaxin

News List

Bharat Biotech announces data from phase-III Covaxin clinical trials expresspharma
July 05, 2021
Covaxin was well-tolerated and the Data Safety Monitoring Board has not reported any safety concerns related to the vaccine, the company said in a statement.
Bharat Biotech Concludes Final Analysis for COVAXIN Efficacy from Phase 3 Clinical Trials firstwordpharma
July 05, 2021
Bharat Biotech announced today safety and efficacy analysis data from Phase III clinical trials of COVAXIN®, a whole virion inactivated vaccine against SARS-CoV2, was developed in partnership with ICMR and NIV Pune.
Covaxin’s Rolling Data to start in July: WHO expresspharma
July 01, 2021
The information was provided on the WHO website in the Status of COVID-19 vaccines within WHO EUL-PQ evaluation process document.
Brazil's Anvisa suspends Covaxin shot's emergency use application firstwordpharma
July 01, 2021
Brazil's health regulator has suspended Covaxin's emergency-use application, which was filed by an intermediary on behalf of the COVID-19 vaccine's developer Bharat Biotech, as reported in This is Money.
Posts on social media misrepresented facts, Covaxin end product doesn’t have newborn calf serum: Centre expresspharma
June 18, 2021
Newborn calf serum is used only for the preparation and growth of vero cells. Serum from bovine and other animal are standard enrichment ingredient used globally for vero cell growth, it said.
Jubilant HollisterStier partners with Ocugen to make Covaxin for US, Canadian markets expresspharma
June 17, 2021
Jubilant HollisterStier has manufacturing units in Spokane (US) and Montreal (Canada).
Ocugen and Jubilant Enter COVID-19 Vaccine Partnership contractpharma
June 16, 2021
Jubilant HollisterStier to manufacture COVAXIN for the U.S. and Canadian markets.
Ocugen to seek full approval for Bharat Biotech’s Covaxin in the US pharmaceutical-technology
June 15, 2021
Ocugen has plans to seek full approval for Bharat Biotech’s Covid-19 vaccine candidate, Covaxin, in the US, after the Food and Drug Administration (FDA) declined to grant an Emergency Use Authorization (EUA).
Bharat Biotech shares full research data of COVAXIN expresspharma
June 15, 2021
Bharat Biotech has shared full data of all research studies of COVAXIN, its COVID-19 vaccine.
Ocugen to apply for full US FDA approval of Covaxin, not for EUA expresspharma
June 15, 2021
Ocugen said the decision was based on a recommendation from the US FDA, which also requested more information and data for full approval.

Previous page 1 2 3 4 5 6 7 8 9 10 11 12 13 Next page